Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about RYR2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
RYR2 is a gene implicated in neurodegeneration research. Key relationships include: activates, implicated in, regulates. Associated with Aging, Als, Cancer. Connected to 54 entities in the SciDEX knowledge graph.
| Gene Symbol | RYR2 |
| Full Name | Ryanodine Receptor 2 |
| Aliases | Page for RYR2 |
| Protein Family | Ryanodine receptor family |
| Protein Type | Channel |
| Function | RYR2 is the cardiac ryanodine receptor, essential for calcium-induced calcium release in heart muscle. |
| Primary Expression | various neuronal populations including hippocampal neurons and cerebellar granule cells, where it contributes to synaptic plastic |
| Molecular Weight | 565 kDa |
| Amino Acids | 647 aa |
| Exons | 105 |
| Pathways | Apoptosis, Nf-Κb, Oxidative Phosphorylation |
| UniProt ID | Q92736 |
| GeneCards | RYR2 |
| Human Protein Atlas | RYR2 |
| FKBP12.6 (calstabin-2) | Stabilizes the closed state of RYR2 |
| Associated Diseases | ALS, Aging, Cancer, Cardiac, Heart Failure |
| Interactions | RAC1, LMNA, VEGFA, EXERCISE, NEUROINFLAMMATION, EPILEPSY |
| KG Connections | 99 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
RYR2["<b>RYR2</b>"]
Als{"Als"}
RYR2 -->|"inhibits"| Als
Cardiac{"Cardiac"}
RYR2 -->|"inhibits"| Cardiac
Ms{"Ms"}
RYR2 -->|"inhibits"| Ms
Ischemia{"Ischemia"}
RYR2 -->|"inhibits"| Ischemia
RYR2 -->|"expressed in"| Als
RYR2 -->|"associated with"| Cardiac
Cardiovascular{"Cardiovascular"}
RYR2 -->|"therapeutic target"| Cardiovascular
Diabetes{"Diabetes"}
RYR2 -->|"therapeutic target"| Diabetes
Obesity{"Obesity"}
RYR2 -->|"therapeutic target"| Obesity
RYR2 -->|"therapeutic target"| Cardiac
RYR2 -->|"therapeutic target"| Ms
RYR2 -->|"associated with"| Als
DRP1["DRP1"]
DRP1 -->|"inhibits"| RYR2
IL6["IL6"]
IL6 -->|"activates"| RYR2
style RYR2 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Cardiac | regulates | disease | 0.75 |
| Als | inhibits | disease | 0.65 |
| Cardiac | inhibits | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Ischemia | inhibits | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Cardiac | associated_with | disease | 0.65 |
| Cardiovascular | therapeutic_target | disease | 0.65 |
| Diabetes | therapeutic_target | disease | 0.65 |
| Obesity | therapeutic_target | disease | 0.65 |
| Cardiac | therapeutic_target | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Epilepsy | activates | disease | 0.65 |
| Neuroinflammation | activates | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Cancer | implicated_in | disease | 0.65 |
| Aging | implicated_in | disease | 0.65 |
| Als | implicated_in | disease | 0.65 |
| Heart Failure | implicated_in | disease | 0.65 |
| Aging | regulates | disease | 0.65 |
| Inflammation | protects_against | disease | 0.65 |
| Cardiac | protects_against | disease | 0.65 |
| Cancer | associated_with | disease | 0.65 |
| Tumor | therapeutic_target | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| ALS | associated_with | disease | 0.65 |
| CAT | expressed_in | gene | 0.60 |
| RYR1 | associated_with | gene | 0.60 |
| RYR3 | associated_with | gene | 0.60 |
| RAC1 | activates | gene | 0.60 |
| LMNA | activates | gene | 0.60 |
| VEGFA | activates | gene | 0.60 |
| SCN1A | regulates | gene | 0.60 |
| ROBO1 | associated_with | gene | 0.60 |
| GAD2 | regulates | gene | 0.60 |
| PIK3CB | regulates | gene | 0.60 |
| NOS1 | regulates | gene | 0.60 |
| CFTR | regulates | gene | 0.60 |
| EPHB4 | associated_with | gene | 0.60 |
| MMP2 | associated_with | gene | 0.60 |
| HIP1R | regulates | gene | 0.60 |
| TP53 | associated_with | gene | 0.60 |
| LRP1B | associated_with | gene | 0.60 |
| EGFR | associated_with | gene | 0.60 |
| EXERCISE | inhibits | gene | 0.60 |
| DIABETES MELLITUS | therapeutic_target | gene | 0.60 |
| NEUROINFLAMMATION | activates | gene | 0.60 |
| Nf-Κb | activates | pathway | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| DRP1 | inhibits | gene | 0.60 |
| IL6 | activates | gene | 0.60 |
| GAIN | activates | gene | 0.60 |
| TRIM24 | regulates | gene | 0.60 |
| STAT3 | regulates | gene | 0.60 |
| EGFR | associated_with | gene | 0.60 |
| TP53 | associated_with | gene | 0.60 |
| LRP1B | associated_with | gene | 0.60 |
| MUC16 | associated_with | gene | 0.60 |
| EPILEPSY | activates | gene | 0.60 |
| NF-ΚB | activates | gene | 0.60 |
| ASTROCYTES | activates | gene | 0.60 |
| ASTROCYTE | activates | gene | 0.60 |
| BRAIN INJURY | activates | gene | 0.60 |
| AND | activates | gene | 0.60 |
| INFLAMMATION | protects_against | gene | 0.60 |
| AND | protects_against | gene | 0.60 |
| GENES | associated_with | gene | 0.60 |
| APOPTOSIS | therapeutic_target | gene | 0.60 |
| TTN | associated_with | gene | 0.60 |
| CANCER | associated_with | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
| RNA | activates | gene | 0.60 |
| PD-1 | activates | gene | 0.60 |
| RNA | therapeutic_target | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||